10 Life Skills You Should Master by Age 30
6 Unusual Ways to Make Money From Home
How to Get the Most From Your Airline Miles
Social Sell-Off: How Experts Are Trading the Carnage
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.